|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/10 | |
| A61K 31/454 | |||
| A61P 35/00 |
| (11) | Number of the document | 2240466 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09700579.7 |
| Date of filing the European patent application | 2009-01-08 | |
| (97) | Date of publication of the European application | 2010-10-20 |
| (45) | Date of publication and mention of the grant of the patent | 2015-07-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2009/000041 |
| Date | 2009-01-08 |
| (87) | Number | WO 2009/087381 |
| Date | 2009-07-16 |
| (30) | Number | Date | Country code |
| 10333 | 2008-01-08 | US |
| (72) |
FOLEY, Jennifer, R., US
WILSON, Robert, Darrin, GB
|
| (73) |
Merck Sharp & Dohme Limited,
Hertford Road, Hoddesdon, Hertfordshire EN11 9BU,
GB
Merck Sharp & Dohme Corp., 126 East Lincoln Avenue, Rahway, NJ 07065-0907, US |
| (54) | PHARMACEUTICALLY ACCEPTABLE SALTS OF 2-{4-[(3S)-PIPERIDIN-3- YL]PHENYL} -2H-INDAZOLE-7-CARBOXAMIDE |
| PHARMACEUTICALLY ACCEPTABLE SALTS OF 2-{4-[(3S)-PIPERIDIN-3- YL]PHENYL} -2H-INDAZOLE-7-CARBOXAMIDE |